Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-24-000197

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 708K sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$11K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$5.63K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $5.23K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $16.23K
Stockholders Equity Q2 2024 · Jun 30, 2024 −$472.64K
Stockholders Equity Q2 2024 · Mar 31, 2024 −$462.97K
Stockholders Equity Q2 2024 · Dec 31, 2023 −$447.2K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$430.31K
Stockholders Equity Q2 2024 · Mar 31, 2023 −$422.12K
Stockholders Equity Q2 2024 · Dec 31, 2022 −$411.34K
Current Liabilities Q2 2024 · Jun 30, 2024 $477.88K
Current Liabilities Q2 2024 · Dec 31, 2023 $463.44K
Total Liabilities Q2 2024 · Jun 30, 2024 $477.88K
Total Liabilities Q2 2024 · Dec 31, 2023 $463.44K
Current Assets Q2 2024 · Jun 30, 2024 $5.23K
Current Assets Q2 2024 · Dec 31, 2023 $16.23K
Total Assets Q2 2024 · Jun 30, 2024 $5.23K
Total Assets Q2 2024 · Dec 31, 2023 $16.23K
Sga Expense Q2 2024 · Jun 30, 2024 $3.95K
Sga Expense Q2 2024 · Jun 30, 2024 $14K
Sga Expense Q2 2024 · Jun 30, 2023 $2.91K
Sga Expense Q2 2024 · Jun 30, 2023 $8.63K
Net Income Q2 2024 · Jun 30, 2024 −$9.67K
Net Income Q2 2024 · Jun 30, 2024 −$25.44K
Net Income Q2 2024 · Mar 31, 2024 −$15.77K
Net Income Q2 2024 · Jun 30, 2023 −$8.19K
Net Income Q2 2024 · Jun 30, 2023 −$18.97K
Net Income Q2 2024 · Mar 31, 2023 −$10.78K
Operating Income Q2 2024 · Jun 30, 2024 −$3.95K
Operating Income Q2 2024 · Jun 30, 2024 −$14K
Operating Income Q2 2024 · Jun 30, 2023 −$2.91K
Operating Income Q2 2024 · Jun 30, 2023 −$8.63K